{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:12:47Z","timestamp":1780078367373,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.euroneuro.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T20:17:27Z","timestamp":1367439447000},"page":"872-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Schizophrenia, antipsychotics and risk of hip fracture: A population-based analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Holger J.","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe O.W.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmi","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.04.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-9964(01)00321-8","article-title":"Bone mineral density and prolactin associations in patients with chronic schizophrenia","volume":"59","author":"Abraham","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.08m04818yel","article-title":"Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study","volume":"71","author":"Baandrup","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/JCP.0b013e31817d5943","article-title":"Fracture risk from psychotropic medications: a population-based analysis","volume":"28","author":"Bolton","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a017956","article-title":"Epidemiology of hip fractures","volume":"19","author":"Cumming","year":"1997","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.22679","article-title":"Atypical antipsychotic use and risk of fracture in persons with Parkinsonism","volume":"24","author":"Dore","year":"2009","journal-title":"Movement Disord."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/schbul\/22.3.447","article-title":"Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes","volume":"22","author":"Halbreich","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","article-title":"Risk of hip fracture in patients with a history of schizophrenia","volume":"190","author":"Howard","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bone.2005.07.005","article-title":"Risk of hip\/femur fractures in patients using antipsychotics","volume":"37","author":"Hugenholtz","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1532-5415.2011.03372.x","article-title":"Older adults' medication use 6 months before and after hip fracture: a population-based cohort study","volume":"59","author":"Kragh","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4088\/JCP.v68n0616","article-title":"Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study","volume":"68","author":"Liperoti","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish Psychiatric Central Research Register","volume":"39","author":"Mors","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib13","first-page":"82","article-title":"The Danish Psychiatric Central Register","volume":"44","author":"Munk-Jorgensen","year":"1997","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists' attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0447.2010.01576.x","article-title":"10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia","volume":"122","author":"Nielsen","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbq137","article-title":"Risk factors for ileus in patients with schizophrenia","volume":"38","author":"Nielsen","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2012.03.003","article-title":"Geographical and temporal variations in clozapine prescription for schizophrenia","author":"Nielsen","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000337746","article-title":"The association between physical morbidity and subtypes of severe depression","volume":"82","author":"Ostergaard","year":"2013","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/11317660-000000000-00000","article-title":"Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study","volume":"26","author":"Panula","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PSY.0b013e3181f7abd3","article-title":"Skeletal status in psychotic disorders: a population-based study","volume":"72","author":"Partti","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-008-0826-5","article-title":"Antipsychotic use and the risk of hip\/femur fracture: a population-based case-control study","author":"Pouwels","year":"2009","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.2009.08091400","article-title":"Childhood motor coordination and adult schizophrenia spectrum disorders","volume":"166","author":"Schiffman","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.161.4.751","article-title":"Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism","volume":"161","author":"Sullivan","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.002_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","article-title":"Psychotropic medications and the risk of fracture: a meta-analysis","volume":"30","author":"Takkouche","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.schres.2011.03.001","article-title":"Characteristics and predictors of long-term institutionalization in patients with schizophrenia","volume":"131","author":"Uggerby","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib27","first-page":"A4578","article-title":"The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good","volume":"60","author":"Uggerby","year":"2013","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","article-title":"Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture","volume":"17","author":"Vestergaard","year":"2006","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.euroneuro.2013.04.002_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","article-title":"Fracture risk associated with parkinsonism and anti-Parkinson drugs","volume":"81","author":"Vestergaard","year":"2007","journal-title":"Calcif. Tissue Int."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1300120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1300120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T04:27:30Z","timestamp":1539664050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1300120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0924977X1300120X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schizophrenia, antipsychotics and risk of hip fracture: A population-based analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}